Literature DB >> 11147275

Immune responses to intermediate strain IBD vaccine at different levels of maternal antibody in broiler chickens.

K Kumar1, K C Singh, C B Prasad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11147275     DOI： 10.1023/a:1005225501513

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN： 0049-4747            Impact factor:   1.559


× No keyword cloud information.
  6 in total

1.  Letter: Quantitation of antibodies to infectious bursal disease.

Authors:  G A Cullen; P J Wyeth
Journal:  Vet Rec       Date:  1975-10-18       Impact factor: 2.695

2.  Use of infectious bursal disease vaccines in chicks with maternally derived antibodies.

Authors:  P J Wyeth; N J Chettle
Journal:  Vet Rec       Date:  1990-06-09       Impact factor: 2.695

3.  Vaccination of commercial layer chicks against infectious bursal disease with maternally derived antibodies.

Authors:  R D Goddard; P J Wyeth; W C Varney
Journal:  Vet Rec       Date:  1994-09-17       Impact factor: 2.695

4.  Pathogenicity and immunosuppressive properties of infectious bursal disease "intermediate" strains.

Authors:  L A Mazariegos; P D Lukert; J Brown
Journal:  Avian Dis       Date:  1990 Jan-Mar       Impact factor: 1.577

5.  The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease.

Authors:  S H Jeurissen; E M Janse; P R Lehrbach; E E Haddad; A Avakian; C E Whitfill
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

6.  Maternal antibody and its effect on infectious bursal disease immunization.

Authors:  S A Naqi; B Marquez; N Sahin
Journal:  Avian Dis       Date:  1983 Jul-Sep       Impact factor: 1.577
  6 in total
  6 in total

1.  Infectious bursal disease: outbreak investigation, molecular characterization, and vaccine immunogenicity trial in Ethiopia.

Authors:  Aregitu Mekuriaw; Molalegne Bitew; Esyas Gelaye; Bedaso Mamo; Gelagay Ayelet
Journal:  Trop Anim Health Prod       Date:  2017-06-15       Impact factor: 1.559

2.  Evaluation of immune responses by live infectious bursal disease vaccines to avoid vaccination failures.

Authors:  P Jakka; Y K Reddy; J J Kirubaharan; N D J Chandran
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

3.  Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.

Authors:  Marina Arnold; Vijay Durairaj; Egbert Mundt; Katja Schulze; Karin D Breunig; Sven-Erik Behrens
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

4.  Determination of the optimal time of vaccination against infectious bursal disease virus (Gumboro) in Algeria.

Authors:  Omar Besseboua; Abdelhanine Ayad; Hama Benbarek
Journal:  Onderstepoort J Vet Res       Date:  2015-04-30       Impact factor: 1.792

5.  Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.

Authors:  Omid Taghavian; Holger Spiegel; Rüdiger Hauck; Hafez M Hafez; Rainer Fischer; Stefan Schillberg
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

6.  Development of a Novel Assay Based on Plant-Produced Infectious Bursal Disease Virus VP3 for the Differentiation of Infected From Vaccinated Animals.

Authors:  Alessio Bortolami; Marcello Donini; Carla Marusic; Chiara Lico; Charifa Drissi Touzani; Federica Gobbo; Elisa Mazzacan; Andrea Fortin; Valentina Maria Panzarin; Francesco Bonfante; Selene Baschieri; Calogero Terregino
Journal:  Front Plant Sci       Date:  2021-12-07       Impact factor: 5.753
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.